Faron Pharmaceuticals Oy (LON:FARN) Stock Price Crosses Above 50 Day Moving Average – What’s Next?

Faron Pharmaceuticals Oy (LON:FARN) passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 186.65 and traded as high as GBX 191.90. Faron Pharmaceuticals Oy shares last traded at GBX 191.90, with a volume of 4,968 shares changing hands.

Faron Pharmaceuticals Oy Stock Performance

The stock’s 50-day moving average price is GBX 186.65 and its 200 day moving average price is GBX 203.60. The firm has a market cap of £218.58 million, a P/E ratio of -7.11 and a beta of 0.36. The company has a debt-to-equity ratio of 922.55, a current ratio of 1.45 and a quick ratio of 1.09.

Faron Pharmaceuticals Oy Company Profile

Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.